Preliminary clinical trial of tetrahydropapaveroline in Parkinson's disease
Dordain, G.; Goujet, M.A.; Simon, P.
Therapie 29(3): 421-434
1974
ISSN/ISBN: 0040-5957 PMID: 4612860 Document Number: 71865
Document emailed within 1 workday
Related Documents
Cubells, J.M.; Hernando, C. 1988: Clinical trial on the use of cytidine diphosphate choline in Parkinson's disease Clinical Therapeutics 10(6): 664-671Jiménez Jiménez, F.J.; Ladero Quesada, J.M. 1990: An experimental model of Parkinson disease caused by a neurotoxin: implications in the clinical aspects and the etiology of Parkinson disease Medicina Clinica 94(15): 585-595
Poungvarin, N.; Viriyavejakul, A. 1990: L-deprenyl therapy in Thai patients with Parkinson's disease: before and after, clinical trial of 50 patients Journal of the Medical Association of Thailand 73(7): 381-386
Campbell, A.M.; Williams, M.J. 1972: Trial of amantadine in Parkinson's disease British Journal of Clinical Practice 26(1): 19-22
Yao, Y.; Zhou, Y.; Hua, Q. 2019: Comparing efficacy and safety of regorafenib versus pemetrexed in lung cancer: a preliminary clinical trial evaluating effect of inflammatory biomarkers on disease progression Pakistan Journal of Pharmaceutical Sciences 32(3 Special): 1293-1299
Overduin, L.M. 1992: Clinical trial on sustained-release phenytoin. Preliminary results of the open, non-controlled study. the Phenytoin Trial Group on Canine Epilepsy Tijdschrift Voor Diergeneeskunde 117(Suppl 1): 27s-28s
Fiszer, U. 1989: Study of the immunologic status of persons with Parkinson disease with special reference to the effect of levodopa treatment. Preliminary report Neurologia i Neurochirurgia Polska 23(1): 7-11
Tanasanvimon, S.; Ayuthaya, N.I.N.; Phanthumchinda, K. 2007: Modified Parkinson's Disease Sleep Scale (MPDSS) in Thai Parkinson's disease patients Journal of the Medical Association of Thailand 90(11): 2277-2283
Fomina, I.G.; Logunova, L.V.; Kuleshov, N.P.; Markova, Z.S. 2001: Inheritance of Wolff-Parkinson-White syndrome and evolution of its clinical symptoms in families of patients in a prospective trial Klinicheskaia Meditsina 79(3): 26-30
Hattori, N. 2004: Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease Rinsho Shinkeigaku 44(4-5): 241-262
Mbuyamba, P. 1986: Clinical trial with CO-1177: a preliminary report International Journal of Clinical Pharmacology Research 6(2): 119-121
Poewe, W.; Gerstenbrand, F. 1986: Clinical subtypes of Parkinson disease Wiener Medizinische Wochenschrift 136(15-16): 384-387
Sale, P.; De Pandis, M.F.; Vimercati, S.L.; Sova, I.; Foti, C.; Tenore, N.; Fini, M.; Stocchi, F.; Albertini, G.; Franceschini, M.; Galli, M. 2013: The relation between Parkinson's disease and ageing. Comparison of the gait patterns of young Parkinson's disease subjects with healthy elderly subjects European Journal of Physical and Rehabilitation Medicine 49(2): 161-167
Barbeau, A. 1972: Biochemical and clinical correlations in Parkinson's disease Revue Neurologique (Paris) 127(2): 253-264
Castaigne, P.; Laplane, D.; Dordain, G. 1971: Clinical experimentation with apomorphine in Parkinson's disease Research Communications in Chemical Pathology and Pharmacology 2(2): 154-158
Smolentseva, I.G.; Chupina, L.P.; Amosova, N.A.; Krivonos, O.V. 2014: Clinical evaluation of Parkinson's disease progression Zhurnal Nevrologii i Psikhiatrii Imeni S.S. Korsakova 114(6 Part 2): 36-40
Al-Bunyan, M.A. 2000: Parkinson`s disease. Clinical and electrophysiology evaluation Neurosciences 5(1): 46-49
Goetz, C.G. 1999: Hallucinations in Parkinson's disease: the clinical syndrome Advances in Neurology 80: 419-423
Remy, P. 2003: Is functional imaging useful in the clinical evaluation of Parkinson's disease? Revue Neurologique (Paris) 159(5 Part 2): 3s57-3s61
Poewe, W.H. 1994: Clinical aspects of motor fluctuations in Parkinson's disease Neurology 44(7 Suppl 6: S6-S9